Relations of Plasma High-Sensitivity C-Reactive Protein to Various Cardiovascular Risk Factors

Ryu, So-Yeon;Lee, Young-Sun;Park, Jong;Kang, Myeng-Geun;Kim, Ki-Soon

  • Published : 20050600

Abstract

This study was performed to evaluate the relation of high-sensitivity C-reactive protein (hsCRP) with several cardiovascular risk factors such as age, blood pressure, smoking habit and serum lipids, body mass index, blood glucose, regular exercise, alcohol drinking, white blood cell counts in a cross-sectional survey. Plasma hsCRP was measured by immunoturbidimetry in 202 subjects, aged over 50 yr, who participated in health-check survey in a rural area of Jeollanamdo, Korea. Plasma hsCRP level was $1.9{\pm}3.0\;mg/dL$. There were significant associations between hsCRP levels and age, white blood cell counts, blood glucose, diastolic blood pressure, HDL-cholesterol, body mass index and smoking status. In stepwise multivariate regression analysis, white blood cell counts, age, blood glucose, smoking status and body mass index were independent correlates of hsCRP levels. In conclusion, plasma hsCRP levels were associated with several cardiovascular risk factors, and these data are compatible with the hypothesis that CRP levels may be a marker for preclinical cardiovascular disease. Further what we need now are prospective studies to evaluate the association of C-reactive protein concentrations with subsequent cardiac events.

Keywords

References

  1. BMJ v.321 Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis Danesh, J.;Whincup, P.;Walker, M.;Lennon, L.;Thomson, A.;Appleby, P.;Gallimore, J.;Pepys, M.B. https://doi.org/10.1136/bmj.321.7255.199
  2. Clin Chem v.47 High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease Rifai, N.;Ridker, P.M.
  3. N Engl J Med v.336 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men Ridker, P.M.;Cushman, M.;Stampfer, M.J.;Tracy, R.P.;Hennekens, C.H. https://doi.org/10.1056/NEJM199704033361401
  4. N Engl J Med v.342 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women Ridker, P.M.;Hennekens, C.H.;Buring, J.E.;Rifai, N. https://doi.org/10.1056/NEJM200003233421202
  5. Lancet v.349 Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Haverkate, F.;Thompson, S.G.;Pyke, S.D.;Gallimore, J.R.;Pepys, M.B. https://doi.org/10.1016/S0140-6736(96)07591-5
  6. Am J Epidemiol v.144 Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial Kuller, L.H.;Tracy, R.P.;Shaten, J.;Meiahn, E.N.
  7. Atherosclerosis v.167 Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors Saito, M.;Ishimitsu, T.;Minami, J.;Ono, H.;Ohrui, M.;Matsuoka, H. https://doi.org/10.1016/S0021-9150(02)00380-5
  8. Circulation v.105 Inflammation and atherosclerosis Libby, P.;Ridker, P.M.;Maseri, A. https://doi.org/10.1161/hc0902.104353
  9. Aterioscler Thromb Vasc Biol v.19 Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women Hak, A.E.;Stehouwer, C.D.;Bots, M.L;Poldennan, K.H.;Schalkwijk, C.G.;Westendorp, J.C.;Hofman, A.;Witteman, J.C.
  10. Am J Epidemiol v.153 Association between physical activity and markers of inflammation in a healthy elderly population Geffken, D.;Cushman, M.;Burke, G.L.;Polak, J.F.;Sakkinen, P.A.;Tracy, R.P. https://doi.org/10.1093/aje/153.3.242
  11. J Nutr Biochem v.13 C-reactive protein and coronary artery disease: influence of obesity Heilbronn, L.K.;Clifton, P.M. https://doi.org/10.1016/S0955-2863(02)00187-0
  12. Circulation v.105 Weight loss reduces C-reactive protein levels in obese postmenopausal women Tchemof, A.;Nolan, A.;Sites, C.;Ades, P.A.;Poehlman, E.T. https://doi.org/10.1161/hc0502.103331
  13. BMJ v.312 C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study Mendall, M.A.;Patel, P.;BaHam, L.;Strachan, D.;Northfield, T.C.
  14. Am J Cardiol v.84 Survey of C-reactive protein and cardiovascular riskfactors in apparently healthy men Rohde, L.E.;Hennekens, C.H.;Ridker, P.M. https://doi.org/10.1016/S0002-9149(99)00491-9
  15. Am Heart J v.121 Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease Reaven, G.M. https://doi.org/10.1016/0002-8703(91)90434-J
  16. N Engl J Med v.340 Atherosclerosis-an inflammatory disease Ross, R. https://doi.org/10.1056/NEJM199901143400207
  17. Circulation v.89 Site of intimal rupture or erosion of thrombosed coronary athersclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology van der Wal, A.C.;Becker, A.E.;van der Laos, C.M.;Das, P.K.
  18. N Engl J Med v.336 Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon Maseri, A. https://doi.org/10.1056/NEJM199704033361409
  19. JAMA v.290 C-reactive protein and the risk of developing hypertension Sesso, H.D.;Bruing, J.E.;Rifai, N.;Blake, G.J.;Gaziano, J.M.;Ridker, P.M. https://doi.org/10.1001/jama.290.22.2945
  20. Arterioscler Thromb Vasc Biol v.22 Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women Bermudez, E.A.;Rifai, N.;Buring, J.;Manson, J.E.;Ridker, P.M. https://doi.org/10.1161/01.ATV.0000029781.31325.66
  21. Circulation v.107 C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells; implications for the metabolic syndrome and atherothrombosis Devaraj, S.;Xu, D.Y.;Jialal, I. https://doi.org/10.1161/01.CIR.0000052617.91920.FD
  22. Circulation v.107 C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Wang, C.H.;Li, S.H.;Weisel, R.D.;Fedak, P.W.;Dumont, A.S.;Szmitko, P.;Li, R.K.;Mickle, D.A.;Verma, S. https://doi.org/10.1161/01.CIR.0000061916.95736.E5
  23. Lancet v.357 Effect of alcohol consumption on systemic markers of inflammation Imhof, A.;Froehlich, M.;Brenner, H.;Boeing, H.;Pepys, M.E.;Koenig, W. https://doi.org/10.1016/S0140-6736(00)04170-2
  24. JAMA v.282 Elevated C-reactive protein levels in overweight and obese adults Visser, M.;Bouter, L.M.;McQuillan, G.M.;Wener, M.H.;Harris, T.B. https://doi.org/10.1001/jama.282.22.2131
  25. J Nutr Biochem v.13 C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss Heilbronn, L.;Clifton, P.M. https://doi.org/10.1016/S0955-2863(02)00187-0
  26. J Assoc Fam Med v.24 The association between C-reactive protein and obesity among Korean men Hwang, J.S.;Lee, S.H.;Park, H.S.
  27. Med Sci Sports Exerc v.35 Body mass index, but not physical activity, is associated with C-reactive protein Rawson, E.S.;Freedson, P.S.;Osganian, S.K.;Matthews, C.E.;Reed, G.;Ockene, I.S. https://doi.org/10.1249/01.MSS.0000074565.79230.AB
  28. Atherosclerosis v.176 Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease Verdaet, D.;Dendale, P.;De Bacquer, D.;Delanghe, J.;Block, P.;De Backer, G. https://doi.org/10.1016/j.atherosclerosis.2004.05.007